News
23h
Vietnam Investment Review on MSNBioCity s SC0062 wins breakthrough status for kidney disease treatmentBioCity Biopharma ("BioCity") announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results